Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination
Abstract Background We examined the efficacy of olanzapine/fluoxetine combination (OFC) in improving health-related quality of life (QoL) in the treatment of bipolar depression in children and adolescents. Methods Patients aged 10-17 years with bipolar I disorder, depressed episode, baseline childre...
Saved in:
Main Authors: | Daniel J. Walker (Author), Melissa P. DelBello (Author), John Landry (Author), Deborah N. D'Souza (Author), Holland C. Detke (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses
by: Azam Bakhtiarian, et al.
Published: (2014) -
Pharmacotherapy of adolescent depression - fluoxetine monotherapy or combined treatment?
by: Cesneková D., et al.
Published: (2017) -
Metabolic and behavioral effects of olanzapine and fluoxetine on the model organism Caenorhabditis elegans
by: Abdullah Almotayri, et al.
Published: (2021) -
Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
by: Taro Kishi, et al.
Published: (2019) -
Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration
by: Zain Mohd, et al.
Published: (2012)